Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 2566 AL 2580

7-(2-(4-(2-Fluoro-4-[(123)I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine

Chopra A.

2013 Apr 22 [updated 2013 Jun 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Prions and the potential transmissibility of protein misfolding diseases

Kraus A, Groveman BR, Caughey B.

Annu Rev Microbiol. 2013;67:543-64. doi: 10.1146/annurev-micro-092412-155735. Epub 2013 Jun 28.

Huntington's disease and Huntington's disease-like syndromes: an overview

Gövert F, Schneider SA.

Curr Opin Neurol. 2013 Aug;26(4):420-7. doi: 10.1097/WCO.0b013e3283632d90.

Chorea gravidarum: a rarity in West still haunts pregnant women in the East

Pathania M, Upadhyaya S, Lali BS, Sharma A.

BMJ Case Rep. 2013 Jun 27;2013:bcr2012008096. doi: 10.1136/bcr-2012-008096.

A treatable new cause of chorea: beta-ketothiolase deficiency

Buhaş D, Bernard G, Fukao T, Décarie JC, Chouinard S, Mitchell GA.

Mov Disord. 2013 Jul;28(8):1054-6. doi: 10.1002/mds.25538. Epub 2013 Jul 1.

Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases

Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K.

Biochim Biophys Acta. 2013 Oct;1830(10):4860-71. doi: 10.1016/j.bbagen.2013.06.029. Epub 2013 Jun 29.

Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis

Lee CY, Cantle JP, Yang XW.

FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31.

Antioxidant activity of galantamine and some of its derivatives

Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, Saso L.

Curr Med Chem. 2013;20(36):4595-608. doi: 10.2174/09298673113209990148.

Voxel-based morphometry with templates and validation in a mouse model of Huntington's disease

Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA.

Magn Reson Imaging. 2013 Nov;31(9):1522-31. doi: 10.1016/j.mri.2013.06.001. Epub 2013 Jul 6.

Polyphenols: multipotent therapeutic agents in neurodegenerative diseases

Bhullar KS, Rupasinghe HP.

Oxid Med Cell Longev. 2013;2013:891748. doi: 10.1155/2013/891748. Epub 2013 Jun 6.

The pridopidine paradox in Huntington's disease

Reilmann R.

Mov Disord. 2013 Sep;28(10):1321-4. doi: 10.1002/mds.25559. Epub 2013 Jul 11.

Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury

Yu F, Wang Z, Tanaka M, Chiu CT, Leeds P, Zhang Y, Chuang DM.

J Neurosurg. 2013 Sep;119(3):766-73. doi: 10.3171/2013.6.JNS13135. Epub 2013 Jul 12.

Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders

Sharma S, Kumar K, Deshmukh R, Sharma PL.

Eur J Pharmacol. 2013 Aug 15;714(1-3):486-97. doi: 10.1016/j.ejphar.2013.06.038. Epub 2013 Jul 10.

Impairment of autophagy: from hereditary disorder to drug intoxication

Aki T, Funakoshi T, Unuma K, Uemura K.

Toxicology. 2013 Sep 15;311(3):205-15. doi: 10.1016/j.tox.2013.07.001. Epub 2013 Jul 10.

[Advances of researches on caspases in neurodegenerative diseases]

Xue H, Fang X, Wang W, Gao G.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Apr;30(2):438-42.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias